![Thomas Mathers](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Mathers
Directeur Général chez
Déclion Pharmaceuticals, Inc.
Profil
Thomas P.
Mathers was the founder of Allievex Corp.
(2018), holding the title of President, Chief Executive Officer & Director.
Mr. Mathers is the founder of Déclion Pharmaceuticals, Inc. (2011), holding the title of Chairman & Chief Executive Officer.
Current jobs include Executive Chairman & Chief Executive Officer at Aer Therapeutics, Inc., Director at Biotechnology Innovation Organization, Partner at Pappas Capital LLC (2018), Trustee at Butler University, and General Partner at AM Pappas Life Science Ventures V (2018).
Former jobs include Chief Executive Officer at CoLucid Pharmaceuticals, Inc. (2017), President & Chief Executive Officer at Peptimmune, Inc. (2003-2011), President & Chief Executive Officer at Cell Based Delivery, Inc. (2002-2003), Director at Cary Street Partners LLC, Director at Biotechnology Innovation Organization, Director & General Manager at CureFAktor Pharmaceuticals LLC (2012-2014), Independent Director at Lifesci Acquisition II Corp., Principal at Pfizer Inc., Vice President-Strategic Development at Genzyme Corp.
(1993-2001), Principal at Snowden Pencer, Inc., Vice President & General Manager at Cardion GmbH (2001-2002), and Captain at The United States Army (District of Columbia) (1991).
Education includes an undergraduate degree from US Military Academy (1988).
Postes actifs de Thomas Mathers
| Sociétés | Poste | Début |
|---|---|---|
Déclion Pharmaceuticals, Inc.
 Déclion Pharmaceuticals, Inc. Déclion Pharmaceuticals, Inc. is a private company based in Boxford, MA. The company was founded in 2011. | Directeur Général | 01/01/2011 |
Pappas Capital LLC
 Pappas Capital LLC Investment ManagersFinance Pappas Ventures invests in companies located in the across the globe and primarily in United States, Canada and Asia. The firm focuses on next-generation life science, agriculture, and technology. It participates in seed and early-stage transactions. | Private Equity Investor | 10/04/2018 |
AM Pappas Life Science Ventures V | Corporate Officer/Principal | 01/02/2018 |
Butler University
 Butler University Other Consumer ServicesConsumer Services Functions as a College/University | Directeur/Membre du Conseil | - |
Aer Therapeutics, Inc.
 Aer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company to treat lung disease | Directeur Général | - |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Directeur/Membre du Conseil | - |
Anciens postes connus de Thomas Mathers
| Sociétés | Poste | Fin |
|---|---|---|
Allievex Corp.
 Allievex Corp. Pharmaceuticals: OtherHealth Technology Develops and manufactures novel therapies for the treatment of rare pediatric neurodegenerative diseases | Fondateur | 01/11/2024 |
| COLUCID PHARMACEUTICALS INC | Directeur Général | 01/07/2017 |
CureFAktor Pharmaceuticals LLC | Directeur/Membre du Conseil | 01/12/2014 |
| ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Thomas Mathers
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
80
Relations au 1er degré
19
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Cary Street Partners LLC
 Cary Street Partners LLC Investment ManagersFinance Provides wealth & investment management, financial planning and advisory services | Finance |
CoLucid Pharmaceuticals, Inc.
 CoLucid Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurological disorders | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Snowden Pencer, Inc.
 Snowden Pencer, Inc. Medical SpecialtiesHealth Technology Manufactures medical supplies | Health Technology |
Pappas Capital LLC
Pappas Capital LLC Investment ManagersFinance Pappas Ventures invests in companies located in the across the globe and primarily in United States, Canada and Asia. The firm focuses on next-generation life science, agriculture, and technology. It participates in seed and early-stage transactions. | Finance |
Cardion GmbH
 Cardion GmbH Medical SpecialtiesHealth Technology Integrates synergistic local gene delivery stem cell engineering and tolerance induction capabilities to build cardiovascular gene therapy products | Health Technology |
Peptimmune, Inc.
 Peptimmune, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
Butler University
Butler University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
US Military Academy
 US Military Academy Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The United States Army (District of Columbia)
 The United States Army (District of Columbia) SovereignGovernment Engages in army operations | Government |
Cell Based Delivery, Inc. | |
Déclion Pharmaceuticals, Inc.
Déclion Pharmaceuticals, Inc. Déclion Pharmaceuticals, Inc. is a private company based in Boxford, MA. The company was founded in 2011. | |
CureFAktor Pharmaceuticals LLC | |
Allievex Corp.
Allievex Corp. Pharmaceuticals: OtherHealth Technology Develops and manufactures novel therapies for the treatment of rare pediatric neurodegenerative diseases | Health Technology |
Lifesci Acquisition II Corp.
 Lifesci Acquisition II Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
AM Pappas Life Science Ventures V | |
Aer Therapeutics, Inc.
Aer Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates biopharmaceutical company to treat lung disease | Health Technology |
